V I S I T
WORLD’S CLINICAL LABORATORY NEWS LEADER ISSN 1068-1760
I
N
T
Early-Stage Pancreatic Cancer Screening Test
P
ancreatic cancer, a lethal tumor of the pancreas, has one of the highest mortality rates among all major cancers. Every year, this disease claims approximately 466,000 lives worldwide, ranking it as the seventh most common cause of cancer-related
Cont’d on page 24
Vol.40 No.4 • 7/2023
E
R
N
A
T
I
DAILY CLINICAL LAB NEWS
®
O
Simple Paper-Based Test Simultaneously Quantifies Multiple Cardiac Biomarkers
C
entralized lab testing has long been the go-to method for diagnosing common illnesses. However, this approach often necessitates costly medical equipment and complex procedures that can only be carried out by highly trained profes-
sionals within a medical facility. These factors prolong testing time and hinder the widespread application of diagnostics in remote and resource-poor areas due to limited access to central labs. In response to these challenges, point-of-care (POC) Cont’d on page 13
Metagenomics Much Faster in Diagnosing Antibiotic Resistant Bloodstream Infections
M
etagenomic sequencing can offer antimicrobial resistance predictions for treating bloodstream infections much faster than conventional laboratory tests, thus saving lives and improving antibiotic management.
See article on page 17
V
I
S
I
T
LINKXPRESS COM
R E A D E R
S E R V I C E
®
P O R T A L
Renew/Start your Free Subscription Access Interactive Digital Magazine Instant Online Product Information: Identify LinkXpress codes of 1 interest as you read magazine ®
on LinkXpress.com 2 toClick reach reader service portal Mark code(s) of interest on 3 LinkXpress inquiry matrix ®
If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
N
I
A
L
Detecting Parkinson’s in Brain Cell Proteins
t’s estimated that 1% of individuals aged over 60 are affected by Parkinson’s disease. Unfortunately, diagnosing this kind of neurodegenerative disease is challenging, with cognitive and movement tests sometimes taking over a year to confirm the diagnosis. Early diagnostic molecular tests could speed up interventions and help Parkinson’s patients receive treatment faster. Cont’d on page 14
New Procalcitonin Testing Guidelines
A
lthough procalcitonin tests have been employed in Europe for years, they were only introduced in the U.S. in 2017 when the FDA approved their use for guiding antibiotic treatment and predicting the likelihood of death within 28 days for sepsis patients. Given their recent arrival in the U.S., there remains uncertainty about the appropriate use of these Cont’d on page 28
AI-Powered Automatic Hematology Analyzer Features RET Indicator
A
s the amount of information generated by hematology analyzers increases, clinicians can be affected by excessive workload, resulting in overlooking of critical information. Now, a cutting-edge hematology analyzer applies artificial intelligence (AI) analysis to generate truly interpretable information which helps decrease Cont’d on page 12
Joint World-European Laboratory Medicine Congress Breaks Attendance Records
T
he 25th IFCC WorldLab and 25th EFLM EuroMedLab were jointly held at the new Rome Convention Center “The Cloud”, on May 21-25, 2023. Hosted by the Italian national society SIBioC, the event was attended by 11,500 professionals plus some 2,000 online participants from over the
world. The congress featured a rich program of plenary lectures, accredited symposia, educational workshops, as well as 2,140 poster presentations. LabMedica’s review of exhibition highlights starts on page 4, while page 29 features a conference wrap-up by Congress President Prof. Sergio Bernardini.
INSIDE
WorldLab ’23 Report. . 4 LabMedica EXPO . 6-28 Clinical News. . .10-28 IFCC News. . . . . . . . 29 Industry News .. . . . 33 Events Calendar.. . 34 PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GLOBETECH >>> MEDIA <<<